您的位置:PharmaNews → 研发动态 → 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

Basilea Pharmaceutica AG (CH) - Data on Basilea's Toctino in Daily Medical Practice in Germany Presented at Dermatology Congress(3)
本文章共3575字,分3页,当前第3页,快速翻页:

For further information, please contact:

Media Relations

Investor Relations

Adesh Kaul Head Public Relations & Corporate Communications +41 61 606 1460 media_relations@basilea.com

Barbara Zink, Ph.D., MBA Head Corporate Development

+41 61 606 1233 investor_relations@basilea.com

 

 转载自pharmaLive


 

 

点这里复制本页地址     发送给您QQ/MSN上的好友


相关文章

•  Orexigen Therapeutics Announces Publicat

•  Geron to Proceed with First Human Clinic

•  Bionovo to Advance Menerba to Phase 3 Cl

•  deCODE Shows how Genetic Risk of Kidney

•  New pathway to Parkinson's and Alzheimer

•  Plant Compound Resveratrol Shown to Supp

•  WaferGen Announces Purchase of SmartChip

•  Researchers Solve Mystery of Uner Tan Sy

•  Shionogi Inc. Announces FDA Approval of

•  Abraxis BioScience and Specialised Thera

Study Results Show That Oral Contracepti

勃林格殷格翰糖尿病药物linagliptin一项Ⅲ期

厄洛替尼在欧盟提交申请用于具EGFR 活化突变

诺华公司肾癌治疗药物依维莫司新适应证研究

罗氏发布在研糖尿病药taspoglutide的Ⅲ期临

罗氏正式提交赫赛汀第二代共轭化合物曲妥珠

达沙替尼申请用于慢性髓性白血病一线治疗

动脉血管瘤支架有望成为新一代畅销介入治疗

相关评论

    
本文章所属分类:首页 → 研发动态